Skip to content

Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics

Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02049359
Acronym
SAMI
Enrollment
170
Registered
2014-01-30
Start date
2014-01-31
Completion date
2016-03-31
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes

Brief summary

The purpose of this study is to determine the impact of two-way short message service (SMS) on glycemic control in low-income, poorly-controlled adult diabetic patients.

Detailed description

This multi-center, unblinded, prospective randomized controlled trial will enroll adult diabetic patients of the Wilson Community Health Center, Harvest Family Health Center, and Freedom Hill Community Health Center living below 200% of 2013 poverty level with a serum hemoglobin A1C \>9% and who currently own a mobile device with text messaging capacity. After written informed consent has been obtained, subjects will be randomized to intervention or control group (1:1), stratified based on insulin initiation within 1 week of study inclusion. Participants randomized to the intervention group will be further divided into subgroups as insulin user or non-insulin user and both will receive SMS messages every 7 days. The content of the message consist of medication reminders, reporting of blood glucose results, insulin technique assessment (if applicable), or d) medication adherence assessment. Participants will be asked to respond with a simple text within 7 days. The intervention group will receive the standard medical appointment reminder via telephone one to two business days prior to the appointment at the Health Center PLUS a unidirectional text message two business days prior to scheduled health center appointments. Control group participants will receive the standard medical appointment reminder via telephone one to two business days prior to the appointment at the health center. All participants in the study (control and intervention) will undergo venipuncture at 3 months (+/-) 2 weeks for the determination of hemoglobin A1C. Demographic information, and frequency of hemoglobin A1C concentrations in the past 6 months will be assessed at baseline. Each week for 12 weeks, the number of texts sent per week and by type, percent of respondents weekly by text or by phone, content of participant responses, number of patients unable to be reached via text, total investigator time spent per week, and time spent per contact will be recorded. At the three month visit, the hemoglobin A1C concentration, blood transfusions since study initiation, and medication changes will be recorded.

Interventions

OTHERTexting

Bidirectional texting once weekly for 12 weeks

Sponsors

Campbell University, Incorporated
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* New or existing patient of Carolina Family Health Centers Inc. (Wilson Community Health Center, Harvest Family Health Center, Freedom Hill Community Health Center) * Diagnosis of diabetes * Single serum hemoglobin A1C equal to or greater than 9% within 2 weeks of study enrollment * Below 200% of 2013 poverty level * Currently own a mobile device with text messaging capacity and anticipated service for duration of 12 week study period

Exclusion criteria

* Anemia diagnosed within past 3 months * Blood transfusion within the past 3 months * unable to read English at the fifth grade level

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline A1C12 weeksChange in A1C from baseline

Secondary

MeasureTime frameDescription
Change in A1C Based on Age, Gender, Race, Type and Duration of Diabetes12 weeksChange in A1C from baseline based on age, gender, race, type and duration of diabetes

Countries

United States

Participant flow

Participants by arm

ArmCount
Control Group
Care as usual; no bidirectional texting
69
Texting
Bidirectional texting weekly for 12 weeks Texting: Bidirectional texting once weekly for 12 weeks
56
Total125

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up2619

Baseline characteristics

CharacteristicControl GroupTextingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants5 Participants9 Participants
Age, Categorical
Between 18 and 65 years
65 Participants51 Participants116 Participants
Age, Continuous50.4 years
STANDARD_DEVIATION 9.7
52.5 years
STANDARD_DEVIATION 10.3
51.3 years
STANDARD_DEVIATION 10
Race/Ethnicity, Customized
African American
50 Participants42 Participants92 Participants
Race/Ethnicity, Customized
Caucasian
15 Participants10 Participants25 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants1 Participants3 Participants
Race/Ethnicity, Customized
Other
2 Participants3 Participants5 Participants
Region of Enrollment
United States
69 Participants56 Participants125 Participants
Sex: Female, Male
Female
41 Participants32 Participants73 Participants
Sex: Female, Male
Male
28 Participants24 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 950 / 75
serious
Total, serious adverse events
0 / 950 / 75

Outcome results

Primary

Change From Baseline A1C

Change in A1C from baseline

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Control GroupChange From Baseline A1C1.1 percentage of A1C decrease
TextingChange From Baseline A1C1.4 percentage of A1C decrease
Secondary

Change in A1C Based on Age, Gender, Race, Type and Duration of Diabetes

Change in A1C from baseline based on age, gender, race, type and duration of diabetes

Time frame: 12 weeks

Population: Change in A1C percentage from baseline by demographic characteristics

ArmMeasureGroupValue (MEAN)
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesAge 18-352.1 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes36-55 years1.2 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes56-65 years0.5 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes>65 years0.8 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesAfrican American1.2 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesCaucasian1.0 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesHispanic2.0 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesOther1.0 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesFemale0.9 percentage of A1C decrease
Control GroupChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesMale1.4 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesOther3.0 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesAge 18-351.9 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesCaucasian1.4 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes36-55 years1.4 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesMale1.5 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes56-65 years1.5 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesHispanic0.9 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of Diabetes>65 years1.2 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesFemale1.3 percentage of A1C decrease
TextingChange in A1C Based on Age, Gender, Race, Type and Duration of DiabetesAfrican American1.3 percentage of A1C decrease

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026